We are live on ! Find out more
Adage Capital Partners

Adage Capital Partners Portfolio holdings

AUM $64.8B
1-Year Est. Return 42.7%
This Fund
S&P 500
This Quarter Est. Return
+1.53%
1 Year Est. Return
+42.7%
3 Year Est. Return
+139.29%
5 Year Est. Return
+204.38%
10 Year Est. Return
+829.83%
AUM
$64.8B
AUM Growth
-$1.23B
Cap. Flow
+$395M
Cap. Flow %
0.61%
Top 10 Hldgs %
28.4%
Holding
1,116
New
212
Increased
277
Reduced
389
Closed
160

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$330M
2
CTRA
Coterra Energy
CTRA
+$214M
3
BSX icon
Boston Scientific
BSX
+$204M
4
RBA icon
RB Global
RBA
+$183M
5
CVX icon
Chevron
CVX
+$131M

Top Sells

Rank Stock Value
1
RNAM
Avidity Biosciences
RNAM
+$190M
2
RPRX icon
Royalty Pharma
RPRX
+$187M
3
DOV icon
Dover
DOV
+$178M
4
BA icon
Boeing
BA
+$168M
5
DVN icon
Devon Energy
DVN
+$155M

Sector Composition

Rank Sector Weight
1 Technology 27.24%
2 Healthcare 15.45%
3 Financials 12.46%
4 Industrials 9.23%
5 Communication Services 8.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TVTX icon
376
Travere Therapeutics
TVTX
$5.33B
$29M 0.04%
977,000
-1,950,000
-67% -$58.3M
AMP icon
377
Ameriprise Financial
AMP
$46.8B
$28.8M 0.04%
64,768
+9,900
+18% +$4.77M
GTM
378
ZoomInfo Technologies
GTM
$861M
$28.4M 0.04%
4,750,000
+1,750,000
+58% +$12.9M
LH icon
379
Labcorp
LH
$24.3B
$28.3M 0.04%
106,000
-41,000
-28% -$11.1M
SPG icon
380
Simon Property Group
SPG
$74.5B
$28.2M 0.04%
151,363
+26,200
+21% +$5M
SHO icon
381
Sunstone Hotel Investors
SHO
$2.19B
$27.9M 0.04%
3,100,000
+1,200,000
+63% +$11M
KYMR icon
382
Kymera Therapeutics
KYMR
$9.1B
$27.9M 0.04%
335,000
-95,000
-22% -$7.52M
IRD
383
Opus Genetics
IRD
$254M
$27.4M 0.04%
6,029,775
+4,924,779
+446% +$17M
CCXI
384
Churchill Capital Corp XI
CCXI
$762M
$27.4M 0.04%
+2,700,000
New +$27.5M
XENE icon
385
Xenon Pharmaceuticals
XENE
$6.32B
$27.3M 0.04%
470,000
-215,100
-31% -$9.91M
CARR icon
386
Carrier Global
CARR
$57.2B
$27.2M 0.04%
482,600
-45,900
-9% -$2.72M
KBON
387
Karbon Capital Partners Corp
KBON
$444M
$27.2M 0.04%
+2,700,000
New +$27.2M
BWA icon
388
BorgWarner
BWA
$13.2B
$27.1M 0.04%
500,000
-50,000
-9% -$2.64M
CGON icon
389
CG Oncology
CGON
$6.11B
$27.1M 0.04%
+399,858
New +$22.7M
SSD icon
390
Simpson Manufacturing
SSD
$7.98B
$27M 0.04%
157,500
+7,500
+5% +$1.38M
FISV
391
Fiserv Inc
FISV
$27.2B
$26.9M 0.04%
481,581
-3,700
-0.8% -$229K
EVR icon
392
Evercore
EVR
$13.1B
$26.8M 0.04%
+89,900
New +$29.4M
DOW icon
393
Dow Inc
DOW
$21.6B
$26.8M 0.04%
642,800
+1,100
+0.2% +$34.9K
IBKR icon
394
Interactive Brokers
IBKR
$40.9B
$26.8M 0.04%
399,000
-3,100
-0.8% -$221K
CRAN
395
Crane Harbor Acquisition Corp II
CRAN
$475M
$26.8M 0.04%
+2,700,000
New +$26.9M
PAYX icon
396
Paychex
PAYX
$40.4B
$26.7M 0.04%
289,446
+112,000
+63% +$11.1M
NWSA icon
397
News Corp Class A
NWSA
$14.5B
$26.6M 0.04%
1,068,520
-32,800
-3% -$813K
CTRE icon
398
CareTrust REIT
CTRE
$10.2B
$26.4M 0.04%
720,000
-80,000
-10% -$3.07M
ODFL icon
399
Old Dominion Freight Line
ODFL
$48.5B
$26.3M 0.04%
134,800
-36,887
-21% -$6.88M
LNTH icon
400
Lantheus
LNTH
$6.82B
$26.3M 0.04%
+346,755
New +$24.9M
14 15
16
17 18

Similar funds

Baird Financial Group
Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $63.6B AUM 28.76% 1-Year Est. Return
GQG Partners
GQG Partners Ft. Lauderdale, Florida $63.1B AUM 23.07% 1-Year Est. Return
Caisse de Depot et Placement du Quebec (CDPQ)
Caisse de Depot et Placement du Quebec (CDPQ) Montreal, Quebec, Canada $62.4B AUM 23.7% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $62.2B AUM 31.35% 1-Year Est. Return
ProShare Advisors
ProShare Advisors Bethesda, Maryland $67.5B AUM 28.09% 1-Year Est. Return

Adage Capital Partners's Q1 2026 Portfolio in Review

As of Q1 2026, Adage Capital Partners held 1,116 positions worth $64.8B, down 1.9% from $66.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Adage Capital Partners's Q1 2026 filing shows 212 new, 277 increased, 389 reduced and 160 closed positions. Its largest new stake was Takeda Pharmaceutical: 6,424,984 shares worth $119M. The largest sale was Avidity Biosciences, an estimated $190M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, down from 29% a quarter earlier, followed by Healthcare and Financials.

  • Adage Capital Partners's largest Q1 2026 buy was Takeda Pharmaceutical: 6,424,984 shares worth $119M.
  • Adage Capital Partners added most to Revolution Medicines in Q1 2026, an estimated $330M increase.
  • Adage Capital Partners's biggest Q1 2026 reduction was Royalty Pharma, cutting an estimated $187M.
  • Adage Capital Partners fully exited Avidity Biosciences in Q1 2026, selling an estimated $190M.
  • Adage Capital Partners's ten largest holdings make up 28% of its $64.8B portfolio in Q1 2026.
  • Adage Capital Partners opened 212 new positions and closed 160 in Q1 2026.
  • Adage Capital Partners's portfolio value fell 1.9% quarter-over-quarter to $64.8B.

Based on Adage Capital Partners's 13F filing for Q1 2026, filed 15 May 2026.